| Cell line name |
114551-080-T-J1-PDC |
| Accession |
CVCL_F4D5 |
| Resource Identification Initiative |
To cite this cell line use: 114551-080-T-J1-PDC (RRID:CVCL_F4D5) |
| Comments |
Part of: NCI Patient-Derived Model Repository. Population: African; Yoruba in Ibadan, Nigeria (YRI). Characteristics: tumorigenic in NOD/SCID/IL2RgammaNULL (NSG) mice. Characteristics: Established from a patient-derived xenograft (PDX) in NOD/SCID/IL2RgammaNULL (NSG) mice. Doubling time: 27 hours (NCI-PDMR=12781). Microsatellite instability: Stable (MSS) (NCI-PDMR=12781). Omics: Genomics; Whole exome sequencing. Omics: Transcriptomics; RNAseq. Derived from site: Metastatic; Lung, pleura; UBERON=UBERON_0000977. |
| Sequence variations |
- Mutation; HGNC; HGNC:20893; BCOR; Simple; p.R1231Gfs*7 (c.3691del); Zygosity=Heterozygous; Note=Likely Oncogenic, variant allele frequency: 0.4118 (NCI-PDMR=12781).
- Mutation; HGNC; HGNC:18185; ERRFI1; Simple; MUTATED (c.-73-1G>A); Zygosity=Heterozygous; Note=Likely Oncogenic, variant allele frequency: 0.4737 (NCI-PDMR=12781).
- Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.R222* (c.664C>T); Zygosity=Heterozygous; Note=Likely Oncogenic, variant allele frequency: 0.5321 (NCI-PDMR=12781).
- Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.R479Q (c.1436G>A); Zygosity=Heterozygous; Note=Oncogenic, variant allele frequency: 0.4397 (NCI-PDMR=12781).
- Mutation; HGNC; HGNC:6515; LATS2; Simple; p.P473_A480dup (c.1416_1439dup); Zygosity=Heterozygous; Note=Likely Oncogenic, variant allele frequency: 0.4242 (NCI-PDMR=12781).
- Mutation; HGNC; HGNC:10249; ROBO1; Simple; p.R922H (c.2765G>A); Zygosity=Heterozygous; Note=Likely Oncogenic, variant allele frequency: 0.4679 (NCI-PDMR=12781).
- Mutation; HGNC; HGNC:11998; TP53; Simple; p.R175H (c.524G>A); Zygosity=Homozygous; Note=Oncogenic, variant allele frequency: 1 (NCI-PDMR=12781).
- Mutation; HGNC; HGNC:13054; ZMYM3; Simple; p.L85Afs*4 (c.252dup); Zygosity=Heterozygous; Note=Likely Oncogenic, variant allele frequency: 0.4389 (NCI-PDMR=12781).
|
| HLA typing |
Source: NCI-PDMR=12781
| Class I | | HLA-A | A*03:01,30:01 | | HLA-B | B*42:01,49:01 | | HLA-C | C*07:01,17:01 |
|
| Disease |
Malignant Salivary Gland Neoplasm (NCIt: C3811) |
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
| Sex of cell |
Female |
| Age at sampling |
52Y |
| Category |
Cancer cell line |
| STR profile |
Source(s): NCI-PDMR=12781
Markers:| Amelogenin | X |
| CSF1PO | 10,11 |
| D2S1338 | 15,21 |
| D3S1358 | 15,18 |
| D5S818 | 12,13 |
| D7S820 | 10,12 |
| D8S1179 | 12,14 |
| D13S317 | 8,11 |
| D16S539 | 12 |
| D18S51 | 17,21 |
| D19S433 | 13,13.2 |
| D21S11 | 29 |
| FGA | 23,24 |
| TH01 | 8 |
| TPOX | 9,11 |
| vWA | 17 |
Run an STR similarity search on this cell line |
| Cross-references |
| Cell line collections (Providers) |
NCI-PDMR; 12781
|
| Entry history |
| Entry creation | 25-Jun-2026 |
| Last entry update | 25-Jun-2026 |
| Version number | 1 |
|---|